Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Recruiting1
Completed1
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting125%
completed125%
active_not_recruiting125%
terminated125%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Advanced Fibrosis Detection for MASLD in Primary Care

NCT07159386
active_not_recruitingnot_applicable

Nicotine Replacement Therapy Prescribing and Lung Cancer Screening in Hospitalized Patients

NCT07164404
terminatednot_applicable

Motivational Interviewing for Vaccine Uptake in Latinx Adults

NCT06062056
completednot_applicable

Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C

NCT02123212

Clinical Trials (4)

Showing 4 of 4 trials
NCT07159386Not Applicable

Advanced Fibrosis Detection for MASLD in Primary Care

Recruiting
NCT07164404Not Applicable

Nicotine Replacement Therapy Prescribing and Lung Cancer Screening in Hospitalized Patients

Active Not Recruiting
NCT06062056Not Applicable

Motivational Interviewing for Vaccine Uptake in Latinx Adults

Terminated
NCT02123212Not Applicable

Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4